Transient receptor potential melastatin subfamily 3 (TRPM3) ion channels play a role in calcium (Ca 21 ) cell signalling. Reduced TRPM3 protein expression has been identified in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) patients. However, the significance of TRPM3 and association with intracellular Ca 21 mobilization has yet to be determined. Fifteen CFS/ME patients (mean age 48Á82 6 9Á83 years) and 25 healthy controls (mean age 39Á2 6 12Á12 years) were examined. 
Introduction
Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a complex illness presenting with debilitating post-exertional malaise accompanied by other neurological, immunological, autonomic and ion transport impairments [1, 2] . The most consistent biological evidence reported in CFS/ME has been reduced natural killer (NK) cell cytotoxicity (reviewed by Stayer et al. [3] infected, tumour or 'missing self ' cells [4] . Activated NK cells increase CD69 receptors and may be modulated by protein kinase C (PKC) and protein tyrosine kinases [5] . NK cells from CFS/ME patients have been reported to have a significant reduction in CD69 receptors after stimulation [6] . When NK cells come into contact with virus-infected or tumour cells, an immune synapse is formed and degranulation is activated. Degranulation is detected when NK cells increase the lysosome-associated membrane protein-1 (LAMP-1, CD107a) receptor [7] . NK cells require Ca 21 to regulate cellular functions, which play a major role in signalling pathways that are essential for development of immune synapse formation, cytokine production and cytotoxic activity [8] .
Transient receptor potential (TRP) ion channels modulate ion entry in the cell plasma membrane, and are expressed differentially on tissues throughout the body. Their dysfunction has been associated with several diseases, such as cancer, glomerulosclerosis and polycystic kidney disease [9] . Transient receptor potential melastatin 3 ion channels (TRPM3) are transmembrane ion channels belonging to the melastatin subfamily of TRP cation ion channels [10, 11] . There are seven isotypes identified in the human TRPM3 gene; in particular, the TRPM3a2 isotype has been characterized as having a Ca 21 and Mg 21 ionconducting pore [12, 13] . TRPM3 ion channels are expressed in various tissues, predominantly in sensory neurones, kidney, brain, pituitary gland and pancreas. While expressed ubiquitously in mammalian cells, the roles and functions of TRPM3 have yet to be determined in immune cells [10] . TRPM3 ion channels are activated selectively by a potent neurosteroid, pregnenolone sulphate (PregS) [14] . Pregnenolone is synthesized from cholesterol by many tissues, including adrenal glands, brain and skin. These tissues have been reported to express TRPM3 [10] . Physiologically, PregS plays a role in both the central nervous system and immune system, which include improvement of memory and cognitive function, enhanced neuronal myelination, activation of neurotransmitter-gated channels, modulation of glutamate-nitric oxide-guanosine 3 0 ,5 0 -(cyclic) phosphate pathways, regulation of insulin secretion and the management of noxious pain [14, 15] .
Recently, TRPM3 ion channels were identified on NK cells and B cells from CFS/ME patients [16] , and these cells were shown to have significantly reduced expression of the TRPM3 receptor on the cell surface compared with healthy controls (HC) [17] . However, the role of TRPM3 in terms of receptor number and Ca 21 mobilization following stimulants, such as PregS on NK cell function, has not been investigated in CFS/ME patients. Therefore, the objective of this study was to determine the effects of PregS on TRPM3, including CD69 and CD107a receptor expression in NK cells. Additionally, we investigated intracellular Ca 21 mobilization and cytotoxic activity of NK cells after PregS treatment in HC and CFS/ME patients.
Materials and methods

Participants
CFS/ME patients meeting the Fukuda definition were included into the study, along with HC [2] . All participants were recruited between the ages of 18 and 65 years, with no previous history of smoking or chronic disease (autoimmune diseases, cardiac diseases and primary psychological disorders). Participants were further excluded if pregnant, breast feeding or taking hormone therapy and pharmaceutical immunoregulatory medications. Alternatively, participants on immunoregulatory medications were included into the study if medications were discontinued 2 weeks prior to their blood collection.
Participants living in the South East Queensland region of Australia donated 80 ml of blood between 8:00 a.m. and 10:30 a.m. Seventy ml of blood was used to isolate NK cells for further study, while the remaining 10 ml was used for routine pathology screening to help determine any underlying illness. Pathology results included a full blood cell count, electrolytes, erythrocyte sedimentation rate, Creactive protein, dehydroepiandrosterone, adrenocorticotrophic hormone and cortisol. All participants completed a self-reported questionnaire on their current symptoms, which also included the Short-Form Health Survey (SF-36) and WHO Disability Assessment Schedule 2.9 (WHO DAS 20.0) to assess participants' physical health.
Drugs and antibodies
In-vitro assays consisted of using the following drugs at a final concentration of 1 lM ionomycin, 50 lM 2-aminoethoxydiphenyl borate (2-APB), 1Á42 lM thapsigargin (TG) and 1Á35 lM PregS. All drugs were purchased from Bio-Techne (Tocris Bioscience, Sussex, UK) except ionomycin, which was purchased from Sigma (Mansfield, Victoria, Australia). Antibodies CD3, CD56, CD16, CD69 and CD107a were purchased from Beckon Dickinson Bioscience (Miami, FL, USA). TRPM3 primary and secondary antibody was purchased from Santa Cruz Biotechnology (Dallas, TX, USA). Isotypes were used to determine negative cell populations. TRPM3 primary antibody was blocked by peptide amino acids that bind to the 816-897aa of TRPM3 of human origin (Accession number Q9HCF6) and binds to the extracellular domain to determine nonspecific binding.
NK cells
Peripheral blood mononuclear cells (PBMCs) were isolated from ethylenediamine tetraacetic acid (EDTA) whole blood by centrifugation over a density gradient medium (Ficoll; GE Healthcare, Pittsburgh, PA, USA), followed by magnetic isolation for unlabelled NK cells using EasySep, as described by the manufacturer's instructions. Isolated NK cells from PBMCs were determined to be 90Á4% 6 3Á82 purity for CFS/ME patients and 91Á6% 6 5Á61 for HC. 
NK cytotoxic activity
NK cell cytotoxicity baseline measurements were performed using 25 : 1, 12 : 1, 6 : 1 and 1 : 1 effector to target ratios, as described previously [18] . NK cell cytotoxicity activity was measured indirectly through the percentage of CFS/ME groups, as well as within each group. The MannWhitney statistical U-test was used to determine the specific relationship effects between each stimulant (PregS, TG 1 PregS and 2APB 1 PregS) on TRPM3, CD69 and CD107a surface expression on NK cell subsets from CFS/ME patients and HC. The Gaussian smoothing method was applied on the Ca 21 flux response curve, prior to analyses of area under the curve (AUC), time of peak and slope. NK cell cytotoxic activity was measured by the percentage of K562 cell deaths as described by Aubry et al. [18] . Statistical significance was reported at P < 0Á05.
Results
Participants
A total of 40 participants were included in this investigation, 25 of which were HC and 15 were CFS/ME. The participants' demographic and standard serological results were recorded (Table 1 ). There were no significant differences in gender, body mass index (BMI), full blood counts, electrolytes, stress hormones or inflammatory markers between HC and CFS/ME. There was a significant between-group difference for age, as CFS/ME patients were significantly older than HC.
CFS/ME patients reported greater impairment compared with HC in all SF-36 subscales (lower scores indicate greater impairment; P < 0Á05) and WHO DAS 2.0 subscales (higher scores indicate greater impairment; P < 0Á05), as shown in Table 1 . Significantly reduced SF-36 scores and elevated WHO DAS 2.0 scores have been observed previously in other CFS/ME studies [19] [20] [21] within HC and CFS/ME groups demonstrated a significant increase in TRPM3 ion channels (Fig. 2d) . Similarly, CD56 dim CD16
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1 NK cells within both groups increased TRPM3 receptors with TG 1 PregS, TG and ionomycin when compared without stimulation. By comparison, no significant difference was observed after 2APB or 2APB 1 PregS stimulation between or within each of the groups (HC and CFS/ME) (Fig. 2f) . CD69 receptors between groups (data not shown). However, both NK cell subsets within groups showed no significant difference in CD69 receptor numbers between unstimulation and PregS. There was a significant reduction of CD69 receptor after TG and TG 1 PregS stimulations (Fig. S1 ). CD56 dim CD16 1 NK cells within groups showed a further reduction of CD69 receptor after 2APB and ionomycin compared without stimulation. Ca 21 mobilization in NK cell subsets was determined using FlowJo, as shown in Fig. 3 . Each subset Ca 21 response curve was reported as peak time (peak t) to determine the time for a reaction to reach its maximum. Slope is determined as follows: a positive slope implies that the y-axis value is increasing over the time-period, while a negative value implies that it is decreasing. The AUC is cantly increased AUC in CFS/ME compared with controls after PregS (Fig. 4a) . There was no significant difference in the AUC in CD56 dim CD16 1 TRPM3 1 NK cells (Fig. 4b) .
Calcium ion mobilization in natural killer cells
Overall, within both groups there was an increase in AUC after PregS stimulation compared with no stimulation.
NK cytotoxic activity
NK cells demonstrated significantly increased cytotoxic activity when stimulated with TG 1 PregS in CFS/ME compared with the HC group. No significant betweengroup differences were seen with PregS, ionomycin and 2APB (Fig. 5 ).
Discussion
Previous investigations have reported significant reductions in NK cell cytotoxic activity in CFS/ME patients, and the current investigation supports those findings [16] . The current investigation also confirms our previous results of significantly reduced TRPM3 receptors on NK cells as well as significantly reduced intracellular Ca 21 mobilization in isolated NK cells [16] . The current investigation showed inhibition of the ER Ca 21/ ATPase pump and depletion of intracellular Ca 21 stores followed by PregS-activated TRPM3 increased cytotoxic activity in NK cells from CFS/ ME patients (Fig. 6 ). TRPM3 receptors are constitutively open [10, 12, 22] and are activated by steroids [15] , hypotonic cell swelling and Ca 21 store depletion [10] , but these findings are inconsis- cal synapse is not formed, preventing the formation of mitotic spindles for cytoskeleton movement to facilitate the secretory vesicles leading to abnormal lysis of target cells [25] . The deficits identified above may thus contribute to impaired lysis of CFS/ME NK cells. Interestingly, our study supports the finding that ionomycin alone does not improve NK cytotoxic activity, but it elevates TRPM3 expression on CD56 dim CD16 1 NK cells compared with HC. TRPM3 expression is increased when ionomycin raises cytosolic Ca 21 through phospholipase Cdependent mobilization of Ca 21 stores [26] . Prolonged treatment with ionomycin has been reported previously to render NK cells hyporesponsive, and hence these cells probably require a higher signal intensity to mount an effective response [27] .
CFS/ME patients have significantly decreased extracellular-regulated kinase (ERK) 1/2 in CD56 dim CD16
1 NK cells and significantly increased mitogen-activated protein kinase kinase (MEK) 1/2 and p38 in CD56 bright CD16 dim/-NK cells following incubation with K562 cells [28] . ERK 1/2 is activated in a P13K-dependent manner that may also be associated with cytoplasmic Ca 21 ion levels through activation of TRPM3 [10] . In the absence of phosphatidylinositol biphosphate TRPM3 is not activated, resulting in reduced cytosolic Ca 21 [29] . Stimulating CD56 dim CD16 1 NK cells with TG prior to PregS resulted in a significant elevation in cytotoxic activity. error of the mean. Asterisks (*) and (**) represent statistical significance at P < 0Á05 and P < 0Á01, respectively. Abbreviations: US 5 unstimulated; PregS 5 pregnenolone sulphate; TG 5 thapsigargin; HC 5 healthy controls; CFS/ME 5 chronic fatigue syndrome/myalgic encephalomyelitis.
These findings are noteworthy, as it has been reported that depleting intracellular stores with TG increases activity of ERK. Phosphorylation of ERK 1/2 allows polarization of secretory granules for degranulation and therefore increased NK cell lysis in CFS patients [30] [31] [32] . CFS/ME patients have been reported to have a significant reduction in CD69 expression on T cells and NK cells upon stimulation, which may correspond to impaired initial cell activation through a PKC-dependent signalling pathway [6] . However, this current investigation found no significant difference between groups. In vitro, degranulation is activated in NK cells when an immunosynapse is formed between NK cells and K562 tumour cells [7, 33] . During degranulation, cytolytic granules containing lytic proteins are released and CD107a receptors are expressed on the NK cell surface. In the current investigation CD107a was not significantly different between groups, and this finding is supported by others [28] . PKC is activated by elevated intracellular Ca 21 concentration, which activates ERK signalling pathways and transcription factors [32, 34, 35] . Inhibition of PKC has been shown to impaired signaling pathways that activate TRPM3-induced transcription factor activator protein-1 (AP-1) [35] . Our results also show that CD69 is reduced when NK cells are stimulated with TG. However, in combination with PregS stimulation, which facilitates an increase in cytoplasmic Ca 21 and activates PKC and ERK signalling pathways, NK cell cytotoxic activity in CFS/ME patients increased.
The current investigation confirms our previous reports of significant changes in TRPM3 receptor numbers in NK cells in CFS/ME. Following PregS stimulation, however, there was no significant increase in Ca 21 mobilization in CD56 dim CD16 1 NK cells from CFS/ME patients. These novel findings suggest that TRPM3 receptor function is impaired, resulting in impaired Ca 21 mobilization with adverse consequences for homeostasis. As TRPM3 receptors are expressed throughout the human body, the current findings suggest that impaired TRPM3 function may play a significant role in the multisystemic pathomechanism of CFS/ME. Other TRP receptors, such as TRPM1, may possibly have a similar role in CFS/ME pathomechanism due to its sequence homology with TRPM3; however, further investigation is warranted [36] . We have previously identified Fig. 5 . Natural killer (NK) cell cytotoxic activity after incubation with ionomycin, PregS, TG 1 PregS and 2APB 1 PregS in HC and CFS/ME. Note significant elevation of K562 cell death in CFS/ME following TG 1 PregS. Data are represented as mean 6 standard error of the mean. Asterisk (*) represents statistical significance at P < 0Á05. PregS 5 pregnenolone sulphate; 2-APB 5 2-aminoethoxydiphenyl borate; TG 5 thapsigargin; CFS/ME 5 chronic fatigue syndrome/myalgic encephalomyelitis. genomic changes in other TRPs and autonomic receptors, which should be investigated further [17, 37, 38] . The results of this study are considered preliminary, and are limited by our small sample size. Accordingly, we found that our CFS/ME patients were older compared with HC; however, routine pathological screening showed no difference between groups. As CFS/ME is a heterogeneous condition, future directions aim to optimize these findings in a larger cohort. In this pilot study, we characterized our CFS/ ME patients by reduced NK cytotoxic activity compared with HC. We further aimed to capture those with significant functional impairment according to SF-36 and WHO DAS 2.0 disability scores. To define further the role of TRPM3 and Ca 21 , future study will examine findings in distinct clinical phenotypes of CFS/ME to elucidate the distinct physiological effects of this mechanism.
Conclusions
TRPM3 activity and function in NK cells in CFS/ME patients is impaired, resulting in changes in Ca 21 ion concentration in the cytosol and intracellular stores which may, in turn, change the NK cells' activation threshold. Cytotoxic NK cells from CFS/ME patients may attempt to compensate for impaired TRPM3 receptors by increasing intracellular Ca 21 for sufficient NK cell activity. Increasing Ca 21 concentrations to activate the ERK signalling pathway may help to improve NK cell cytotoxicity in CFS/ME. Improvement of Ca 21 -dependent NK activity may help to improve the immune system in CFS/ME patients to facilitate a quicker response to eliminate pathogens. Moreover, improvement of cell-to-cell interaction could improve the development of antigen-specific memory cells. This investigation may inform the pathomechanism of reduced NK cell cytotoxicity in CFS/ME patients.
